Repligen Corporation
RGEN NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 28, 2026
ET
EPS Est.
0.45
EPS Actual
0.54
Revenue Est.
$201.6M
Revenue Actual
$204.1M
Next Earnings Report
Date
Oct 27, 2026 · Tue
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
0.46
Revenue Est.
$206.8M
Company Overview
Repligen Corporation (ticker RGEN) is listed on NASDAQ with a market cap of about $10.22B. Its next earnings report (FY2026 Q3) is expected on Oct 27, 2026 (ET), Pre-market, with consensus EPS of 0.46. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Feb 22, 2023 → Jul 28, 2026
Feb 22, 2023Range: 0.23 ~ 0.68Jul 28, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 28, 2026 | -- | 0.45 | Above forecast↑0.54 | $201.6M | $204.1M |
| May 5, 2026 | -- | 0.38 | Above forecast↑0.48 | $192.1M | $194.3M |
| Feb 24, 2026 | -- | 0.44 | 0.49 | $192.9M | $197.9M |
| Oct 28, 2025 | -- | 0.42 | 0.46 | $182.1M | $188.8M |
| Jul 29, 2025 | -- | 0.40 | 0.37 | $175.2M | $182.4M |
| Apr 29, 2025 | -- | 0.35 | 0.39 | $163.7M | $169.2M |
| Feb 20, 2025 | -- | 0.41 | 0.44 | $167.6M | $167.5M |
| Nov 12, 2024 | -- | 0.34 | Above forecast↑0.43 | $153M | $154.9M |
| Jul 30, 2024 | -- | 0.33 | 0.33 | $154.1M | $154.1M |
| May 1, 2024 | -- | 0.29 | 0.28 | $150.1M | $151.3M |
| Feb 21, 2024 | -- | 0.34 | 0.33 | $155.4M | $155.7M |
| Oct 31, 2023 | -- | 0.14 | Above forecast↑0.23 | $140.7M | $141.2M |
| Aug 2, 2023 | -- | 0.49 | 0.53 | $165.9M | $159.2M |
| May 2, 2023 | -- | 0.59 | 0.64 | $181.4M | $182.7M |
| Feb 22, 2023 | -- | 0.58 | Above forecast↑0.68 | $184.6M | $186.8M |
Original Filings (SEC)
10-Q2026-07-29 ↗
8-K2026-07-28 ↗
8-K2026-07-22 ↗
8-K2026-05-15 ↗
10-Q2026-05-06 ↗
8-K2026-05-05 ↗
10-K2026-02-26 ↗
8-K2026-02-24 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
